Published: 30 Jan 2022 | Report Code: 10248353 | Pages: 131
Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies. Highlighted with 35 tables and 70 figures, this 131-page report “Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Assay Kits & Consumables • Analyzers & Instruments Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Autoantibodies and Immunologic Tests o Antinuclear Antibody Tests o Anti-cyclic Citrullinated Peptide o Enzyme-Linked Immunosorbent Assay (ELISA) o Rheumatoid Factor o Thyroid Antibody Tests o Other Autoantibodies and Immunologic Tests • Inflammatory Marker Tests o C-Reactive Protein (CRP) o Erythrocyte Sedimentation Rate (ESR) o Other Inflammatory Marker Tests • Routine Laboratory Tests o Urinalysis o Complete Blood Count (CBC) Tests o Other Routine Laboratory Tests • Other Test Types Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Systemic Autoimmune Disease o Rheumatoid Arthritis o Systemic Lupus Erythematosus (SLE) o Psoriasis/Psoriatic Arthritis o Other Systemic Autoimmune Diseases • Localized Autoimmune Disease o Thyroiditis o Multiple Sclerosis o Inflammatory Bowel Disease o Type 1 Diabetes o Other Localized Autoimmune Diseases Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Female Patients • Male Patients Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • < 44 • 44 - 64 • > 64 Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Diagnostic Labs • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc. F. Hoffmann-la Roche Ltd. Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table Of Contents:
1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 14 1.2.6 Market Size/Share Estimation 15 1.2.7 Research Limitations 16 1.3 Executive Summary 17 2 Market Overview and Dynamics 20 2.1 Market Size and Forecast 20 2.1.1 Impact of COVID-19 on World Economy 21 2.1.2 Impact of COVID-19 on the Market 23 2.2 Major Growth Drivers 25 2.3 Market Restraints and Challenges 30 2.4 Emerging Opportunities and Market Trends 33 2.5 Porter’s Fiver Forces Analysis 37 3 Segmentation of Asia Pacific Market by Product 42 3.1 Market Overview by Product 42 3.2 Assay Kits & Consumables 44 3.3 Analyzers & Instruments 45 4 Segmentation of Asia Pacific Market by Test Type 46 4.1 Market Overview by Test Type 46 4.2 Autoantibodies and Immunologic Tests 48 4.2.1 Antinuclear Antibody Tests 50 4.2.2 Anti-cyclic Citrullinated Peptide 51 4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52 4.2.4 Rheumatoid Factor 53 4.2.5 Thyroid Antibody Tests 54 4.2.6 Other Autoantibodies and Immunologic Tests 55 4.3 Inflammatory Marker Tests 56 4.3.1 C-Reactive Protein (CRP) 58 4.3.2 Erythrocyte Sedimentation Rate (ESR) 59 4.3.3 Other Inflammatory Marker Tests 60 4.4 Routine Laboratory Tests 61 4.4.1 Urinalysis 63 4.4.2 Complete Blood Count (CBC) Tests 64 4.4.3 Other Routine Laboratory Tests 65 4.5 Other Test Types 66 5 Segmentation of Asia Pacific Market by Disease Type 67 5.1 Market Overview by Disease Type 67 5.2 Systemic Autoimmune Disease 69 5.2.1 Rheumatoid Arthritis 71 5.2.2 Systemic Lupus Erythematosus (SLE) 72 5.2.3 Psoriasis/Psoriatic Arthritis 73 5.2.4 Other Systemic Autoimmune Diseases 74 5.3 Localized Autoimmune Disease 75 5.3.1 Thyroiditis 77 5.3.2 Multiple Sclerosis 78 5.3.3 Inflammatory Bowel Disease 79 5.3.4 Type 1 Diabetes 80 5.3.5 Other Localized Autoimmune Diseases 81 6 Segmentation of Asia Pacific Market by Gender 82 6.1 Market Overview by Gender 82 6.2 Female Patients 84 6.3 Male Patients 85 7 Segmentation of Asia Pacific Market by Age 86 7.1 Market Overview by Age 86 7.2 < 44 88 7.3 44 - 64 89 7.4 > 64 90 8 Segmentation of Asia Pacific Market by End User 91 8.1 Market Overview by End User 91 8.2 Hospitals 93 8.3 Clinics 94 8.4 Diagnostic Labs 95 8.5 Other End Users 96 9 Asia-Pacific Market 2021-2031 by Country 97 9.1 Overview of Asia-Pacific Market 97 9.2 Japan 100 9.3 China 103 9.4 Australia 105 9.5 India 107 9.6 South Korea 109 9.7 Rest of APAC Region 111 10 Competitive Landscape 113 10.1 Overview of Key Vendors 113 10.2 New Product Launch, Partnership, Investment, and M&A 116 10.3 Company Profiles 117 Abbott Laboratories 117 Beckman Coulter, Inc. 119 Biomerieux SA 120 Bio-rad Laboratories Inc. 121 F. Hoffmann-la Roche Ltd. 122 Hemagen Diagnostics Inc. 123 Myriad Genetics Inc. 124 PerkinElmer Inc. (Euroimmun AG) 125 Quest Diagnostics Inc. 126 Siemens Healthineers Inc. 127 Thermo Fisher Scientific Inc. 128 Trinity Biotech PLC 129 Werfen Company (Inova Diagnostics Inc.) 130 RELATED REPORTS 131
List Of Tables:
Table 1. Snapshot of Asia Pacific Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18 Table 2. World Economic Outlook, 2021-2031 22 Table 3. World Health Spending by Region, $ bn, 2013-2020 29 Table 4. Main Product Trends and Market Opportunities in Asia Pacific Autoimmune Disease Diagnostics Market 33 Table 5. Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 42 Table 6. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn 46 Table 7. Asia Pacific Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn 49 Table 8. Asia Pacific Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn 57 Table 9. Asia Pacific Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn 62 Table 10. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 67 Table 11. Asia Pacific Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn 70 Table 12. Asia Pacific Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn 76 Table 13. Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn 82 Table 14. Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn 86 Table 15. Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 91 Table 16. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 98 Table 17. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 102 Table 18. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 102 Table 19. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 102 Table 20. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 104 Table 21. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 104 Table 22. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 104 Table 23. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 106 Table 24. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 106 Table 25. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 106 Table 26. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 108 Table 27. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 108 Table 28. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 108 Table 29. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 110 Table 30. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 110 Table 31. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 110 Table 32. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 112 Table 33. Abbott Laboratories: Company Snapshot 117 Table 34. Abbott Laboratories: Business Segmentation 118 Table 35. Abbott Laboratories: Product Portfolio 118
List Of Figures:
Figure 1. Research Method Flow Chart 12 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15 Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17 Figure 4. Asia Pacific Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 20 Figure 5. Impact of COVID-19 on Business 23 Figure 6. Primary Drivers and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 25 Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28 Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28 Figure 9. Primary Restraints and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 30 Figure 10. Investment Opportunity Analysis 34 Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Autoimmune Disease Diagnostics Market 37 Figure 12. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 43 Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 43 Figure 14. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, $ mn 44 Figure 15. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, $ mn 45 Figure 16. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 47 Figure 17. Asia Pacific Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 47 Figure 18. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, $ mn 48 Figure 19. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, $ mn 50 Figure 20. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, $ mn 51 Figure 21. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, $ mn 52 Figure 22. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, $ mn 53 Figure 23. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, $ mn 54 Figure 24. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, $ mn 55 Figure 25. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, $ mn 56 Figure 26. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, $ mn 58 Figure 27. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, $ mn 59 Figure 28. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, $ mn 60 Figure 29. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, $ mn 61 Figure 30. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, $ mn 63 Figure 31. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, $ mn 64 Figure 32. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, $ mn 65 Figure 33. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, $ mn 66 Figure 34. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 68 Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Disease Type, Value ($ mn) and Share (%) 68 Figure 36. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, $ mn 69 Figure 37. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, $ mn 71 Figure 38. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, $ mn 72 Figure 39. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, $ mn 73 Figure 40. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, $ mn 74 Figure 41. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, $ mn 75 Figure 42. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, $ mn 77 Figure 43. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, $ mn 78 Figure 44. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, $ mn 79 Figure 45. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, $ mn 80 Figure 46. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, $ mn 81 Figure 47. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 83 Figure 48. Asia Pacific Addressable Market Cap in 2022-2031 by Gender, Value ($ mn) and Share (%) 83 Figure 49. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, $ mn 84 Figure 50. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, $ mn 85 Figure 51. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 87 Figure 52. Asia Pacific Addressable Market Cap in 2022-2031 by Age, Value ($ mn) and Share (%) 87 Figure 53. Asia Pacific Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, $ mn 88 Figure 54. Asia Pacific Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, $ mn 89 Figure 55. Asia Pacific Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, $ mn 90 Figure 56. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 91 Figure 57. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 92 Figure 58. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, $ mn 93 Figure 59. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, $ mn 94 Figure 60. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, $ mn 95 Figure 61. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 96 Figure 62. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 98 Figure 63. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 99 Figure 64. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, $ mn 101 Figure 65. Autoimmune Disease Diagnostics Market in China, 2021-2031, $ mn 103 Figure 66. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, $ mn 105 Figure 67. Autoimmune Disease Diagnostics Market in India, 2021-2031, $ mn 107 Figure 68. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, $ mn 109 Figure 69. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, $ mn 111 Figure 70. Growth Stage of Asia Pacific Autoimmune Disease Diagnostics Industry over the Forecast Period 113
Key Players:
Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc. F. Hoffmann-la Roche Ltd. Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)